This Automotive Supplier is Worth More Than Apple

TMFBlacknGold — Sun, 04 Nov 2012 23:11:19 GMT

Ok, not really. But TMF has Magna International (NYSE: MGA) listed with a $910 billion market cap. Good company, but only worth 10% of that figure.

Inteliquent Special Dividend Caution

TMFBlacknGold — Fri, 05 Oct 2012 11:20:08 GMT

Inteliquent (NASDAQ: IQNT) just announced a major setback from one of its largest customers. To "offset" the bad news the company simultaneously announced a one-time special dividend of $3 per share. Since the payout exceeds 25% of the share price there are different rules for when the payout can occur.

Can someone explain the following in regards t...

A Question About Market Data

TMFBlacknGold — Wed, 03 Oct 2012 13:52:31 GMT

Does anyone know the primary source for real-time financial data or fundamentals data? Is it the exchanges themselves (NYSE, NASDAQ, etc)?

This isn't really a problem most investors think about, since anyone with an internet connection can go on Yahoo!, Google Finance, TMF, etc and get intra-day quotes quickly and easily. However, I would like to create software for financial research i.e. "due dili...

Biopharma Run-up is Ruining My CAPS

TMFBlacknGold — Sat, 22 Sep 2012 14:32:11 GMT

The recent summer run-up in the biopharmaceutical industry has been responsible for a loss of over 1,300 of my CAPS points. This is, of course, my fault for shorting them in the first place. I guess I just never thought it could get so out of hand. For instance, my red thumb on Peregrine Pharmaceuticals (NASDAQ: PPHM) is worth almost -900 points since June 1st. I was feeling pretty confide...

CVR Partners Offering 70 million Shares?

TMFBlacknGold — Fri, 31 Aug 2012 13:44:59 GMT

Does anyone know why CVR Partners (NYSE: UAN) is selling 70 million shares? That's nearly the entire float (73 million shares outstanding) and represents $1.32 billion. It can't be CVR Energy's stake in the company, because that would make their stake 96% - which isn't even close.

I have a small position with a great entry point, but I am still concerned (its a huge offering) and can't seem to find any n...

How Do You Research Your Investments?

TMFBlacknGold — Thu, 23 Aug 2012 15:57:07 GMT

I am curious as to how Fools research and do their due diligence. While talking with a friend the other day it struck me how seemingly inefficient it can be to successfully research a company and become well-versed in its operations. This undoubtedly changes given the type of industry a company belongs to; the complexity of a life sciences company such as GenOn (NYSE: GEN) or how the newest

What Does Icahn Mean for CVR Energy's Limited Partnership?

TMFBlacknGold — Thu, 17 May 2012 12:40:58 GMT

Does anyone know how Carl Icahn's takeover of CVR Energy (NYSE: CVI) affects CVR Partners LP (NYSE: UAN)?
I own UAN, but it has not garnered much attention in articles describing the takeover. Will it really be that difficult to sell with CVI's refinery? I figure that if a refiner such as CVI was willing to part...

U.S. Coal Production: Peabody and Arch Coal

TMFBlacknGold — Mon, 23 Jan 2012 18:41:55 GMT

http://beta.fool.com/BlacknGold/2012/01/21/us-coal-production-peabody-and-arch-coal/
Twitter: @BlacknGoldFool

U.S. Energy "Independence": Facts and Truths

TMFBlacknGold — Mon, 23 Jan 2012 18:40:22 GMT

http://beta.fool.com/BlacknGold/2012/01/22/us-energy-independence-facts-and-truths/
Twitter: @BlacknGoldFool

KERX Perifosine Analysis

TMFBlacknGold — Tue, 10 Jan 2012 23:18:33 GMT

The company Keryx Biopharmaceuticals (NASDAQ: KERX) has attracted two types of investors: those who hate KERX and those who love it. Their lead drug candidate, perifosine, is currently in Phase III trials for colorectal cancer - and results are expected within weeks. I bought a total of 981 shares during 2010 and early 2011. I have had plenty of opportunities to sell for a profit, but did not pounce. N...

BlacknGold: U.S. Dependence on Oil

TMFBlacknGold — Mon, 09 Jan 2012 23:05:56 GMT

Four short years ago during the presidential primaries several topics dominated the debates: the wars in Iraq and Afghanistan, the economy, healthcare, and alternative energy. Now in 2012 the Iraq War has officially ended (today actually), the economy is thawing, national healthcare seems to be an afterthought, and alternative energy is trying to hide the black eye named Solyndra. It is still early...

BlacknGold: Introduction to U.S. Energy Consumption

TMFBlacknGold — Sat, 07 Jan 2012 20:39:27 GMT

This is my first blog post engaging the increasingly important topics of energy, oil, biofuels, and surprising technologies by innovative - and perhaps overly optimistic - companies hoping to cash in on the future of energy. For this post, I will provide some background information on energy consumption within the United States. As with all of my posts I will be straightforward, unbiased, and factual. I will make frequent use...

My New CAPS Focus

TMFBlacknGold — Wed, 19 Oct 2011 12:21:21 GMT

As some of you may know, I started out writing a few pharma blogs focused on micro and small-cap biotechnology companies. I enjoyed doing it and learned quite a bit about how to research stocks. Perhaps most importantly I learned how to say no the the great investor folly of "potential", which has lost more money for investors than it has ever made. However, it's very obvious than no one can cover the ...

Immunogen's Drug In the Spotlight

TMFBlacknGold — Sat, 01 Oct 2011 13:45:39 GMT

Tether drugs together to target breast cancer
01 October 2011 Magazine issue 2832.
LINKING two cancer drugs may help women with breast cancer live longer, with fewer side effects.
Chemotherapy drugs target all ...

NYSE Complains About Speed of Light

TMFBlacknGold — Sat, 01 Oct 2011 12:27:03 GMT

Light is not fast enough for high-speed stock trading
01 October 2011 by Jeff Hecht
Magazine issue 2832<...

Cereplast Offers Great Long Term Opportunity

TMFBlacknGold — Fri, 30 Sep 2011 23:51:33 GMT

I won't come out and say that Cereplast (CERP) is the best deal ever - because too many people try to call the next big thing (try allowing Motley Fool to email you their newsletter for a few weeks and you'll see how annoying it can be). But I will come out and say that Cereplast offers a very great long term opportunity.
Now I know what you're thinking: many stocks are currently undervalued due to the market ...

Acient Protein is Potent Antibiotic

TMFBlacknGold — Sat, 24 Sep 2011 11:14:21 GMT

Resurrected ancient protein is a potent antibiotic
24 September 2011 by Wendy Zukerman
Magazine issue
Everyone run and hide! The udderworld is here!
http://www.cnn.com/2011/TECH/innovation/08/18/ibm.brain.chip/index.html?hpt=hp_c1

Experimental Drug Could Defeat Any Virus

TMFBlacknGold — Fri, 12 Aug 2011 11:23:47 GMT

Interesting article from my favorite news site, New Scientist. I post a lot of articles from there, so check back periodically or check out the site yourself.
Article:
Viruses might soon meet their kryptonite: an experimental drug that can, in theory, obliterate cells infected by...

Congress Loves Monkey Business

TMFBlacknGold — Thu, 11 Aug 2011 13:38:17 GMT

In February 2009, Nash was helping a friend coax her 14-year-old pet chimp, Travis, back into the house. When Nash arrived, the chimp, who had been featured in television commercials for Coca-Cola and Old Navy, jumped on her and began biting and mauling her. Police later shot Travis to stop the attack and he died of gunshot wounds.The ...

TMFBlacknGold's Blog

This Automotive Supplier is Worth More Than Apple

Inteliquent Special Dividend Caution

A Question About Market Data

Biopharma Run-up is Ruining My CAPS

CVR Partners Offering 70 million Shares?

How Do You Research Your Investments?

What Does Icahn Mean for CVR Energy's Limited Partnership?

U.S. Coal Production: Peabody and Arch Coal

U.S. Energy "Independence": Facts and Truths

KERX Perifosine Analysis

BlacknGold: U.S. Dependence on Oil

BlacknGold: Introduction to U.S. Energy Consumption

My New CAPS Focus

Immunogen's Drug In the Spotlight

NYSE Complains About Speed of Light

Cereplast Offers Great Long Term Opportunity

Acient Protein is Potent Antibiotic

Experimental Drug Could Defeat Any Virus

Congress Loves Monkey Business